[1] 中国垂体腺瘤协作组.中国垂体催乳素腺瘤诊治共识(2014版)[J].中华医学杂志,2014,94(31):2406-2411. [2] 季立津.泌乳素瘤发病机制研究进展[J].医学综述,2016,22(1):55-59. [3] 王红云,龚磊,刘春晖,等.雌激素受体1在生长激素腺瘤中的表达及意义[J].中华神经外科杂志,2017,33(6):610-614. [4] 陶燕铎,曹纬国,刘志勤,等.黄酮类化合物药理作用的研究进展[J].西北植物学报,2003,23(12):2241-2247. [5] Arivazhagan L, Sorimuthu P S. Tangeretin, a citrus pentamethoxyflav- one, exerts cytostatic effect via p53/ p21 up-regulation and suppresses metastasis in 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinoma[J]. J Nutr Biochem,2014,25(11):1140-1153. [6] 李金艳.橘皮素对人成胶质细胞瘤细胞增殖及凋亡的影响[J].中国老年学杂志,2017,37(12):2891-2893. [7] 杨连君,曹雪涛,于益芝.bcl-2,bax与肿瘤细胞凋亡[J].中国肿瘤生物治疗杂志,2003,10(3):232-234. [8] Kang M H, Reynolds C P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy[J]. Clinical Cancer Research, 2009, 15(4):1126-1132. [9] GillamM P, MolitchM E, Lombardi G, et al. Advances in the treatment of prolactinoma[J]. Endocrine Reviews,2006,27(5):485-534. [10] 孙青芳,卞留贯,赵卫国,等.垂体泌乳素腺瘤的手术治疗[J].中华神经外科杂志,2006,22(2):109-111. [11] Shi M D, Liao Y C, Shih Y W, et al. Nobiletin attenuates metastasis via both ERK and P13K/Akt pathways in HGF-treated liver cancer HepG2 cells[J].Phytomedicine, 2013,20(8-9):743-752. [12] Chen K H, Weng M S, Lin J K. Tangeretin suppresses IL-1 beta-induced eyelooxygenase(COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells[J]. Biochem Pharmaeol,2007,73(2):215-227. [13] 托娅,张和平.乳酸杆菌Lactobacillus casei.Zhang的抗肿瘤作用及机制[J].分子诊断与治疗杂志,2010,2(6):394-399. |